Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Hematological Oncology|December 10, 2015
Impact of exclusion criteria for the DASISION and ENESTnd trials in the front-line treatment of a 'real-life' patient population with chronic myeloid leukaemiaRoberto Latagliata, Ida Carmosino, Federico Vozella, et al.
Cancers|September 27, 2025
CAR-T Cell Therapies in B-Cell Acute Lymphoblastic Leukemia: Emerging Data and Open IssuesCaterina Alati, Martina Pitea, Matteo Molica, et al.
Annals of Hematology|November 28, 2016
Ruxolitinib in clinical practice for primary and secondary myelofibrosis: an analysis of safety and efficacy of Gruppo Laziale of Ph-negative MPNMassimo Breccia, Alessandro Andriani, Marco Montanaro, et al.
European Journal of Haematology|June 14, 2018
Clinical results according to age in patients with chronic myeloid leukemia receiving imatinib frontline: The younger, the later, the worse?Roberto Latagliata, Massimo Breccia, Ida Carmosino, et al.
Cancers|October 14, 2022
Identification of Predictive Factors for Overall Survival and Response during Hypomethylating Treatment in Very Elderly (≥75 Years) Acute Myeloid Leukemia Patients: A Multicenter Real-Life ExperienceMatteo Molica, Carla Mazzone, Pasquale Niscola, et al.
Oncology Research and Treatment|October 9, 2019
Incidence of Clinically Significant (≤10 g/dL) Late Anemia in Elderly Patients with Newly Diagnosed Chronic Myeloid Leukemia Treated with ImatinibLaura Cesini, Ida Carmosino, Massimo Breccia, et al.
Leukemia & Lymphoma|September 2, 2020
Balanced and unbalanced chromosomal translocations in myelodysplastic syndromes: clinical and prognostic significanceSara Mohamed, Roberto Latagliata, Maria Zaira Limongi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 26, 2015
Catheter-associated bloodstream infections and thrombotic risk in hematologic patients with peripherally inserted central catheters (PICC)Salvatore Giacomo Morano, Roberto Latagliata, Corrado Girmenia, et al.
Annals of Hematology|May 3, 2019
Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practiceGiovanni Caocci, Olga Mulas, Elisabetta Abruzzese, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 21, 2020
Clinical and Prognostic Features of Essential Thrombocythemia: Comparison of 2001 WHO Versus 2008/2016 WHO Criteria in a Large Single-center CohortSofia Chiatamone Ranieri, Maria Antonietta Arleo, Stefania Trasarti, et al.
Pageof 9